1-(4-Chlorobenzyl)-1H-indole-3-carbaldehyde

Catalog No. :
ACRJIM124
CAS No. :
75629-57-1
Molecular Formula :
C16H12ClNO
Molecular Weight :
269.73

IUPAC Name:1-(4-chlorobenzyl)-1H-indole-3-carbaldehyde

1-(4-Chlorobenzyl)-1H-indole-3-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%$92.00Login to see priceInquiryInquiry
25mg98%$400.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-Chlorobenzyl)-1H-indole-3-carbaldehyde
IUPAC Name1-(4-chlorobenzyl)-1H-indole-3-carbaldehyde
MDL No.MFCD01051808
Molecular FormulaC16H12ClNO
Molecular Weight269.73
SMILESO=CC1=CN(CC2=CC=C(Cl)C=C2)C3=C1C=CC=C3
InChI KeyZDRQMXCSSAPUMM-UHFFFAOYSA-N
SynonymBP-25398 | ONC-1 | N-4-chlorobenzyl-3-formylindole | FT-0734916 | HY-16662 | 1-[(4-Chlorophenyl)methyl]-1H-indole-3-carbaldehyde | EN300-228659 | STK347777 | BBL015259 | HB0473 | Oncrasin-1, >=98% (HPLC) | N-4-chlorobenzylindole-3-carboxaldehyde | AB00090171-01 | NSC812292 | NSC-812
CAS No.75629-57-1
PubChem CID872445

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313

Synthetic Route by SureRoute

1. ACRJIM124 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOHWJ835 route compound structure diagram
    ACOHWJ835487-89-8 In Stock
  4. Then
  5. ACRJIM124 route product structure diagram
    ACRJIM12475629-57-1
Inquiry

2. ACRJIM124 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOHWJ835 route compound structure diagram
    ACOHWJ835487-89-8 In Stock
  4. Then
  5. ACRJIM124 route product structure diagram
    ACRJIM12475629-57-1
Inquiry

Comments (0)